Bioplus launches new filler product with Brazil's Simed
Predicted impact: Low· Actual: −9.4% vs sector, volume 0.8× normal (5 trading days)
New filler product launch with a Brazilian partner; no deal size given.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.